ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis

Abstract

The angiotensin-converting enzyme (ACE)-related carboxypeptidase, ACE2, is a type I integral membrane protein of 805 amino acids that contains one HEXXH + E zinc-binding consensus sequence. ACE2 has been implicated in the regulation of heart function and also as a functional receptor for the coronavirus that causes the severe acute respiratory syndrome (SARS). To gain further insights into this enzyme, the first crystal structures of the native and inhibitor-bound forms of the ACE2 extracellular domains were solved to 2.2- and 3.0-A resolution, respectively. Comparison of these structures revealed a large inhibitor-dependent hinge-bending movement of one catalytic subdomain relative to the other ( approximately 16 degrees ) that brings important residues into position for catalysis. The potent inhibitor MLN-4760 ((S,S)-2-[1-carboxy-2-[3-(3,5-dichlorobenzyl)-3H-imidazol4-yl]-ethylamino]-4-methylpentanoic acid) makes key binding interactions within the active site and offers insights regarding the action of residues involved in catalysis and substrate specificity. A few active site residue substitutions in ACE2 relative to ACE appear to eliminate the S(2)' substrate-binding subsite and account for the observed reactivity change from the peptidyl dipeptidase activity of ACE to the carboxypeptidase activity of ACE2.

Cited by papers we hold 15

• Convergent evolution of SARS-CoV-2 Omicron subvariants leading to the emergence of BQ.1.1 variant · 2023
  No notice
• In silico investigation of critical binding pattern in SARS-CoV-2 spike protein with angiotensin-converting enzyme 2 · 2021
  Not checked
• SARS-CoV-2 S protein:ACE2 interaction reveals novel allosteric targets · 2021
  No notice
• Engineered ACE2 receptor therapy overcomes mutational escape of SARS-CoV-2 · 2021
  No notice
• Highly conserved binding region of ACE2 as a receptor for SARS-CoV-2 between humans and mammals · 2020
  Not checked
• Genetic alteration, RNA expression, and DNA methylation profiling of coronavirus disease 2019 (COVID-19) receptor ACE2 in malignancies: a pan-cancer analysis · 2020
  Not checked
• Angiotensin‐converting enzyme 2 ( ACE2 ), SARS‐CoV ‐2 and the pathophysiology of coronavirus disease 2019 ( COVID ‐19) · 2020
  No notice
• Structural basis for the recognition of SARS-CoV-2 by full-length human ACE2 · 2020
  No notice
• Molecular docking study of potential phytochemicals and their effects on the complex of SARS-CoV2 spike protein and human ACE2 · 2020
  No notice
• Comparative ACE2 variation and primate COVID-19 risk · 2020
  No notice
• ACE2 gene variants may underlie interindividual variability and susceptibility to COVID-19 in the Italian population · 2020
  No notice
• Master Regulator Analysis of the SARS-CoV-2/Human Interactome · 2020
  No notice
• Mechanisms of Host Receptor Adaptation by Severe Acute Respiratory Syndrome Coronavirus · 2012
  No notice
• Angiotensin‐Converting Enzyme 2: The First Decade · 2011
  No notice
• Sex differences in renal angiotensin converting enzyme 2 (ACE2) activity are 17β-oestradiol-dependent and sex chromosome-independent · 2010
  No notice

Questions about this paper

Reads

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.